$EMMA
Emmaus Life Sciences, Inc.

2020 Q3 Form 10-Q Financial Statement

#000156459021045798 Filed on August 26, 2021

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3
Revenue $5.601M $22.75M $5.760M
YoY Change -2.76% 5777.55% 17.98%
Cost Of Revenue $484.0K $1.094M $248.0K
YoY Change 95.16% 386.01% 75.89%
Gross Profit $5.117M $21.66M $5.512M
YoY Change -7.17% 13269.14% 16.26%
Gross Profit Margin 91.36% 95.19% 95.69%
Selling, General & Admin $4.480M $23.99M $8.834M
YoY Change -49.29% 849.72% 37.9%
% of Gross Profit 87.55% 110.75% 160.27%
Research & Development $629.0K $2.183M $725.0K
YoY Change -13.24% 586.91% 55.58%
% of Gross Profit 12.29% 10.08% 13.15%
Depreciation & Amortization $12.00K $19.00K $16.00K
YoY Change -25.0% -37.09% 23.08%
% of Gross Profit 0.23% 0.09% 0.29%
Operating Expenses $5.109M $26.17M $9.559M
YoY Change -46.55% 820.34% 39.1%
Operating Profit $8.000K -$4.512M -$4.047M
YoY Change -100.2% 68.26% 89.91%
Interest Expense $1.606M -$46.31M $8.714M
YoY Change -81.57% 202127.07% 57.72%
% of Operating Profit 20075.0%
Other Income/Expense, Net $718.0K -$3.109M -$22.46M
YoY Change -103.2% -234.49%
Pretax Income $5.878M -$54.68M -$18.34M
YoY Change -132.06% 1921.82% -225.86%
Income Tax $293.0K $164.0K $56.00K
% Of Pretax Income 4.98%
Net Earnings $5.585M -$54.84M -$18.39M
YoY Change -130.37% 2206.71% -226.24%
Net Earnings / Revenue 99.71% -241.04% -319.31%
Basic Earnings Per Share -$0.60
Diluted Earnings Per Share $114.0K -$1.298M -$0.60
COMMON SHARES
Basic Shares Outstanding 48.47M 45.99M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.949M $29.70M $41.19M
YoY Change -87.98% 1880.13% 1165.52%
Cash & Equivalents $4.949M $1.769M $1.326M
Short-Term Investments $0.00 $27.93M $27.64M
Other Short-Term Assets $572.0K $667.0K $767.0K
YoY Change -25.42% 62.29% 298.23%
Inventory $7.422M $7.971M $7.491M
Prepaid Expenses
Receivables $1.726M $2.150M $1.982M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $40.89M $41.22M $39.98M
YoY Change 2.28% -31.99% 1038.92%
LONG-TERM ASSETS
Property, Plant & Equipment $130.0K $151.0K $163.0K
YoY Change -20.25% -0.66% 47.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $14.48M $13.33M $0.00
YoY Change
Other Assets $291.0K $285.0K $427.0K
YoY Change -31.85% -29.8% 1475.65%
Total Long-Term Assets $19.05M $18.24M $18.12M
YoY Change 5.16% 24.34% 1003.77%
TOTAL ASSETS
Total Short-Term Assets $40.89M $41.22M $39.98M
Total Long-Term Assets $19.05M $18.24M $18.12M
Total Assets $59.94M $59.46M $58.10M
YoY Change 3.18% -21.02% 1027.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.173M $7.277M $7.400M
YoY Change -70.64% 109.95% 2033.18%
Accrued Expenses $4.932M $3.188M $2.446M
YoY Change 101.64% 78.2% 272.02%
Deferred Revenue
YoY Change
Short-Term Debt $1.616M $793.0K $193.0K
YoY Change 737.31%
Long-Term Debt Due $10.66M $13.76M $17.81M
YoY Change -40.15% 982685.71% 1370207.69%
Total Short-Term Liabilities $23.78M $32.83M $31.37M
YoY Change -24.2% -27.94% 2591.87%
LONG-TERM LIABILITIES
Long-Term Debt $3.505M $0.00 $1.200M
YoY Change 192.08% -100.0% 103.46%
Other Long-Term Liabilities $35.44M $33.75M $34.56M
YoY Change 2.55% -6.82% 31286.01%
Total Long-Term Liabilities $42.53M $37.68M $39.50M
YoY Change 7.67% -28.8% 5543.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.78M $32.83M $31.37M
Total Long-Term Liabilities $42.53M $37.68M $39.50M
Total Liabilities $66.31M $70.51M $70.35M
YoY Change -5.74% -27.3% 6120.44%
SHAREHOLDERS EQUITY
Retained Earnings -$226.2M -$224.9M
YoY Change 32.02%
Common Stock $215.3M $212.7M
YoY Change 43.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.365M -$11.05M -$12.17M
YoY Change
Total Liabilities & Shareholders Equity $59.94M $59.46M $58.10M
YoY Change 3.18% -21.02% 1027.72%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income $5.585M -$54.84M -$18.39M
YoY Change -130.37% 2206.71% -226.24%
Depreciation, Depletion And Amortization $12.00K $19.00K $16.00K
YoY Change -25.0% -37.09% 23.08%
Cash From Operating Activities -$2.643M $555.0K $948.1K
YoY Change -378.77% -131.86% -158.21%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$5.000K -$34.20K
YoY Change -100.0% 21.95% -812.5%
Acquisitions
YoY Change
Other Investing Activities $31.76M -$4.000K -$1.420M
YoY Change -2336.48% -41864.71%
Cash From Investing Activities $31.76M -$9.000K -$1.454M
YoY Change -2283.88% 119.51% 80688.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 482.0K 856.0K -2.208M
YoY Change -121.83% -10053.49% -198.72%
NET CHANGE
Cash From Operating Activities -2.643M 555.0K 948.1K
Cash From Investing Activities 31.76M -9.000K -1.454M
Cash From Financing Activities 482.0K 856.0K -2.208M
Net Change In Cash 29.60M 1.402M -2.714M
YoY Change -1190.65% -179.89% -548.03%
FREE CASH FLOW
Cash From Operating Activities -$2.643M $555.0K $948.1K
Capital Expenditures $0.00 -$5.000K -$34.20K
Free Cash Flow -$2.643M $560.0K $982.3K
YoY Change -369.06% -132.22% -160.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 emma Common Stock Purchase Period
CommonStockPurchasePeriod
P5Y
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0028
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0038
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7891
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.8049
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
42529000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
37682000
CY2020Q3 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
45000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.11
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-9473000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-14019000
CY2019Q3 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
131000
CY2019Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
3341000
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
3341000
CY2019Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
18000
us-gaap Interest And Other Income
InterestAndOtherIncome
1318000
us-gaap Interest And Other Income
InterestAndOtherIncome
248000
CY2019Q3 us-gaap Interest Expense
InterestExpense
8714000
us-gaap Interest Expense
InterestExpense
4717000
us-gaap Interest Expense
InterestExpense
25153000
CY2019Q3 emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
-14289000
emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
2094000
emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
-48025000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18336000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1701000
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
51000
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
131000
CY2020Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
6464000
CY2019Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-5248000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
7672000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-22242000
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
36000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1474000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-413000
CY2019Q3 emma Miscellaneous Reverse Merger Cost
MiscellaneousReverseMergerCost
309000
emma Miscellaneous Reverse Merger Cost
MiscellaneousReverseMergerCost
309000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53237000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
56000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
159000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
5585000
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-18392000
us-gaap Profit Loss
ProfitLoss
1621000
us-gaap Profit Loss
ProfitLoss
-53396000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.32
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48866724
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40469601
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-11053000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
142000
CY2020Q1 emma Fair Value Of Warrants Including Down Round Protection Adjustments
FairValueOfWarrantsIncludingDownRoundProtectionAdjustments
400000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
209000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
61000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
5509000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-4732000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
219000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-425000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
193000
CY2020Q3 emma Fair Value Of Warrants Including Down Round Protection Adjustments
FairValueOfWarrantsIncludingDownRoundProtectionAdjustments
1983000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
5585000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-6365000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-21708000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
3374000
CY2019Q1 emma Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
5000
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2530000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
329000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-17408000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-32311000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
5390000
CY2019Q2 emma Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
181000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
731000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
438000
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3000000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
35459000
CY2019Q3 emma Adjustments To Additional Paid In Capital Conversion Note Inducements
AdjustmentsToAdditionalPaidInCapitalConversionNoteInducements
3662000
CY2019Q3 emma Adjustments To Additional Paid In Reclassification Of Warrant Liability To Equity
AdjustmentsToAdditionalPaidInReclassificationOfWarrantLiabilityToEquity
6336000
CY2019Q3 emma Stock Issued During Period Value Merger
StockIssuedDuringPeriodValueMerger
-1642000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
129000
CY2019Q3 emma Adjustments To Fair Value Of Replacement Equity Awards
AdjustmentsToFairValueOfReplacementEquityAwards
2437000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-18392000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-12167000
us-gaap Profit Loss
ProfitLoss
1621000
us-gaap Profit Loss
ProfitLoss
-53396000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54000
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
524000
emma Inventory Reserve
InventoryReserve
-596000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3200000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
21875000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
316000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
207000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
7672000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-21718000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1474000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-413000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1425000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-438000
emma Share Based Compensation And Fair Value Of Replacement Equity Award
ShareBasedCompensationAndFairValueOfReplacementEquityAward
549000
emma Share Based Compensation And Fair Value Of Replacement Equity Award
ShareBasedCompensationAndFairValueOfReplacementEquityAward
3593000
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
3341000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
669000
emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
3492000
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
51000
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
131000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4362000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
186000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
142000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6210000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-78000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3028000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
44000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2787000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-336000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1025000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-313000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4150000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-43000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-82000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3119000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5966000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
500000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-287000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-3883000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
828000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1451000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2363000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4137000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1641000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
35601000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
221000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55000
emma Loans To Equity Method Investee
LoansToEquityMethodInvestee
2274000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
33314000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1475000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1980000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
200000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2000000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3368000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-14000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28860000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2579000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1769000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3905000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30629000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1326000
us-gaap Interest Paid Net
InterestPaidNet
1543000
us-gaap Interest Paid Net
InterestPaidNet
1239000
us-gaap Income Taxes Paid
IncomeTaxesPaid
126000
us-gaap Income Taxes Paid
IncomeTaxesPaid
242000
emma Non Cash Warrants Issued
NonCashWarrantsIssued
3808000
emma Non Cash Beneficial Conversion Feature Relating To Convertible Notes
NonCashBeneficialConversionFeatureRelatingToConvertibleNotes
8764000
emma Warrant Liabilities Reclassification To Equity
WarrantLiabilitiesReclassificationToEquity
6337000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
33777000
emma Conversion Of Accrued Interest Payable To Common Stock
ConversionOfAccruedInterestPayableToCommonStock
2381000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2922000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
19276395
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13457963
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reclassification of prior year presentation<span style="font-weight:normal;">—Certain reclassifications have been made to the prior period amounts to confirm with the current year presentation. </span></p>
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16915000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15960000
CY2019Q4 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
1897000
emma Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year
RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear
5203000
emma Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales
RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales
93000
emma Revenue Allowance And Accrual Activities Credit And Payments Made
RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade
3906000
CY2020Q3 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
3101000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4949000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1326000
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
25680000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30629000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1326000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5601000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5760000
CY2018Q4 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
981000
emma Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year
RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear
3597000
emma Revenue Allowance And Accrual Activities Credit And Payments Made
RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade
2682000
CY2019Q3 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
1896000
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
572000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
667000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1117000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1402000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
483000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
507000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
353000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
356000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
130000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
151000
CY2020Q3 us-gaap Depreciation
Depreciation
12000
CY2019Q3 us-gaap Depreciation
Depreciation
16000
CY2019Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
891000
CY2020Q3 emma Accrued Government Rebates And Other Rebates Current
AccruedGovernmentRebatesAndOtherRebatesCurrent
2465000
CY2019Q4 emma Accrued Government Rebates And Other Rebates Current
AccruedGovernmentRebatesAndOtherRebatesCurrent
1355000
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
474000
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
238000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
969000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
704000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4932000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3188000
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7675000
us-gaap Depreciation
Depreciation
35000
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
524000
CY2020Q3 emma Cro Expenses
CROExpenses
419000
CY2019Q4 emma Cro Expenses
CROExpenses
232000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
636000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1183000
CY2020Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
654000
CY2019Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1303000
CY2020Q3 emma Accrued Manufacturing Expenses Current
AccruedManufacturingExpensesCurrent
112000
CY2019Q4 emma Accrued Manufacturing Expenses Current
AccruedManufacturingExpensesCurrent
4541000
CY2020Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
352000
CY2019Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
18000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2173000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7277000
CY2020Q3 emma Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
47000
CY2019Q4 emma Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
42000
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
523000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
991000
CY2020Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1024000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11498000
CY2020Q3 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
17473000
CY2020Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2491000
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
14982000
us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
4704623
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.00
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8365146
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
35436000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33750000
CY2019Q4 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
17142000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3190000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
13952000
CY2020Q3 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.10
CY2019Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.10
CY2020Q3 emma Debt Weighted Average Effective Interest Rate
DebtWeightedAverageEffectiveInterestRate
0.35
CY2019Q4 emma Debt Weighted Average Effective Interest Rate
DebtWeightedAverageEffectiveInterestRate
0.66
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
6369000
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7732000
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
222000
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3150000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
17473000
CY2020Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.00
CY2020Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2021-04-21
CY2020Q1 emma Convertible Debentures Conversion Price
ConvertibleDebenturesConversionPrice
3.00
CY2020Q1 emma Convertible Debentures Conversion Price
ConvertibleDebenturesConversionPrice
9.52
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.00
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.87
CY2020Q3 emma Warrants Exercisable
WarrantsExercisable
7115146
us-gaap Operating Lease Expense
OperatingLeaseExpense
705000
CY2020Q2 us-gaap Share Price
SharePrice
1.67
CY2019Q2 us-gaap Share Price
SharePrice
10.30
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
2.05
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
10.30
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0183
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6716
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Operating Lease Expense
OperatingLeaseExpense
895000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
282000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1142000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1165000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1050000
CY2020Q3 emma Lessee Operating Lease Liability Payments Due Year Four And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter
2982000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6621000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1933000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4100000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4700000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1275
CY2020Q3 emma Marketable Securities Common Stock Outstanding
MarketableSecuritiesCommonStockOutstanding
4147491
CY2020Q3 emma Percentage Of Marketable Securities Common Stock Outstanding
PercentageOfMarketableSecuritiesCommonStockOutstanding
0.086
CY2020Q3 emma Convertible Bond Maturity Date
ConvertibleBondMaturityDate
2030-10-16
CY2020Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.021
CY2020Q3 emma Convertible Bond Initial Conversion Price
ConvertibleBondInitialConversionPrice
8.00
CY2020Q3 us-gaap Debt Instrument Call Date Earliest
DebtInstrumentCallDateEarliest
2020-09-28

Files In Submission

Name View Source Status
0001564590-21-045798-index-headers.html Edgar Link pending
0001564590-21-045798-index.html Edgar Link pending
0001564590-21-045798.txt Edgar Link pending
0001564590-21-045798-xbrl.zip Edgar Link pending
emma-10q_20200930.htm Edgar Link pending
emma-10q_20200930_htm.xml Edgar Link completed
emma-20200930.xsd Edgar Link pending
emma-20200930_cal.xml Edgar Link unprocessable
emma-20200930_def.xml Edgar Link unprocessable
emma-20200930_lab.xml Edgar Link unprocessable
emma-20200930_pre.xml Edgar Link unprocessable
emma-ex101_6.htm Edgar Link pending
emma-ex311_8.htm Edgar Link pending
emma-ex312_9.htm Edgar Link pending
emma-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending